Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Highly effective and yet non-harmful: Fumaric acid esters to fight MS

26.03.2013
Firewall for nerve cells: RUBIN covers research reports
Success made in Bochum: Treatment of relapsing-remitting multiple sclerosis

Multiple sclerosis (MS) is a disease for which no cure has yet been found. Its progression may be delayed thanks to new drugs, but the active ingredients in those drugs are either only partially effective or may lead to severe side effects.

Recent developments in the field of dermatology have given rise to hope. Researchers in Bochum have discovered that MS symptoms are considerably alleviated through the application of an active pharmaceutical ingredient on the basis of fumaric acid that has long been successfully used against psoriasis.

Patients suffered 50% fewer flare-ups and the number of active inflammatory foci was reduced by up to 90%. Researchers have now discovered in what way fumaric acid esters protect nerve cells. Their report has been published in the international edition of RUBIN, the science magazine issued by the Ruhr University Bochum.

RUBIN online

The complete article with downloadable images may be found online at
http://www.ruhr-uni-bochum.de/rubin/rubin-international-2013/beitraege/beitrag1.html

MS: Most common neurological cause of disabilities in young adults.

Multiple sclerosis is the most common neurological cause of disabilities in young adults. In Germany, it currently affects some 130,000 patients. In MS patients, the body’s own immune system attacks the nerve fibres’ “insulating layer” and destroys it. Typically, all regions of the brain and the spinal cord are affected as the disease progresses. The inflammations result in ataxia, impairment of fine motor skills, as well as concentration loss, bladder function impairment, fatigue and depressive episodes.

Fruit acid approved for use in the food industry

Since the 1990s, various drugs that delay the progression of the disease by altering the immune system have been available. They are not harmful, yet their efficacy is quite limited. Particularly serious cases are treated with chemotherapeutic agent, which, however, may have severe, even life-threatening side effects. Researchers in Bochum have now discovered that an agent long known in the field of dermatology is highly effective in the treatment of MS episodes: fumaric acid ester. Fumaric acid is a fruit acid found in numerous plants and an approved food acidulant that also occurs naturally in the human body. The active agent has been successfully utilised in psoriasis therapy.

50% fewer episodes, 90% fewer inflammation foci

The discovery happened quite by accident: the MS symptoms of patients who suffered from both MS and psoriasis were alleviated following fumaric acid ester treatment. Accordingly, several studies were carried out. Prof Dr Ralf Gold’s team of neurologists have now presented the proof of fumaric acid ester’s efficacy: it triggers protective metabolic pathways in cells. “Nerve cells are thus protected, as if by a firewall, from inflammatory agents, mainly from free radicals and nitrogen monoxide,” explains Prof Gold. A large-scale study with more than 2,400 patients revealed that fumaric acid esters reduce MS episode frequency by up to 50% and the number of inflammatory foci visible in MRI scans by up to 90%. By changing the drug formula, indigestion, a common side effect of fumaric acid ester occurring in some 400 patients treated by the dermatological drug has been considerably reduced to some 3% to 5%. “Highly efficient and yet non-harmful – a wholly new experience in MS therapy!” Prof Gold says happily.
Bibliographic record

Ralf Gold et al.: Placebo-Controlled Phase 3 Study of Oral BG-12 for Relapsing Multiple Sclerosis. In: N Engl J Med 2012; 367:1098-1107, September 20, 2012, DOI: 10.1056/NEJMoa1114287

Further information

Prof Dr med Ralf Gold, Director at the Neurology Clinic of the Ruhr University Bochum at St. Josef-Hospital, phone 0234/509-2410, ralf.gold@rub.de

Editor: Meike Drießen

Dr. Josef König | idw
Further information:
http://www.ruhr-uni-bochum.de/rubin/rubin-international-2013/beitraege/beitrag1.html

More articles from Health and Medicine:

nachricht Organ-on-a-chip mimics heart's biomechanical properties
23.02.2017 | Vanderbilt University

nachricht Researchers identify cause of hereditary skeletal muscle disorder
22.02.2017 | Klinikum der Universität München

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Breakthrough with a chain of gold atoms

In the field of nanoscience, an international team of physicists with participants from Konstanz has achieved a breakthrough in understanding heat transport

In the field of nanoscience, an international team of physicists with participants from Konstanz has achieved a breakthrough in understanding heat transport

Im Focus: DNA repair: a new letter in the cell alphabet

Results reveal how discoveries may be hidden in scientific “blind spots”

Cells need to repair damaged DNA in our genes to prevent the development of cancer and other diseases. Our cells therefore activate and send “repair-proteins”...

Im Focus: Dresdner scientists print tomorrow’s world

The Fraunhofer IWS Dresden and Technische Universität Dresden inaugurated their jointly operated Center for Additive Manufacturing Dresden (AMCD) with a festive ceremony on February 7, 2017. Scientists from various disciplines perform research on materials, additive manufacturing processes and innovative technologies, which build up components in a layer by layer process. This technology opens up new horizons for component design and combinations of functions. For example during fabrication, electrical conductors and sensors are already able to be additively manufactured into components. They provide information about stress conditions of a product during operation.

The 3D-printing technology, or additive manufacturing as it is often called, has long made the step out of scientific research laboratories into industrial...

Im Focus: Mimicking nature's cellular architectures via 3-D printing

Research offers new level of control over the structure of 3-D printed materials

Nature does amazing things with limited design materials. Grass, for example, can support its own weight, resist strong wind loads, and recover after being...

Im Focus: Three Magnetic States for Each Hole

Nanometer-scale magnetic perforated grids could create new possibilities for computing. Together with international colleagues, scientists from the Helmholtz Zentrum Dresden-Rossendorf (HZDR) have shown how a cobalt grid can be reliably programmed at room temperature. In addition they discovered that for every hole ("antidot") three magnetic states can be configured. The results have been published in the journal "Scientific Reports".

Physicist Dr. Rantej Bali from the HZDR, together with scientists from Singapore and Australia, designed a special grid structure in a thin layer of cobalt in...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Booth and panel discussion – The Lindau Nobel Laureate Meetings at the AAAS 2017 Annual Meeting

13.02.2017 | Event News

Complex Loading versus Hidden Reserves

10.02.2017 | Event News

International Conference on Crystal Growth in Freiburg

09.02.2017 | Event News

 
Latest News

From rocks in Colorado, evidence of a 'chaotic solar system'

23.02.2017 | Physics and Astronomy

'Quartz' crystals at the Earth's core power its magnetic field

23.02.2017 | Earth Sciences

Antimicrobial substances identified in Komodo dragon blood

23.02.2017 | Life Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>